Share on StockTwits

CareFusion (NYSE:CFN) Insider Thomas J. Leonard sold 1,250 shares of CareFusion stock on the open market in a transaction dated Monday, July 7th. The shares were sold at an average price of $45.47, for a total value of $56,837.50. Following the completion of the sale, the insider now directly owns 32,053 shares in the company, valued at approximately $1,457,450. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of CareFusion (NYSE:CFN) traded down 1.55% during mid-day trading on Tuesday, hitting $44.55. 1,235,669 shares of the company’s stock traded hands. CareFusion has a 52 week low of $35.01 and a 52 week high of $45.81. The stock has a 50-day moving average of $43.61 and a 200-day moving average of $41.03. The company has a market cap of $9.236 billion and a price-to-earnings ratio of 25.31.

CareFusion (NYSE:CFN) last announced its earnings results on Monday, May 5th. The company reported $0.60 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.62 by $0.02. The company had revenue of $968.00 million for the quarter, compared to the consensus estimate of $986.67 million. During the same quarter in the prior year, the company posted $0.59 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. On average, analysts predict that CareFusion will post $2.31 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Topeka Capital Markets initiated coverage on shares of CareFusion in a research note on Thursday, June 12th. They set a “hold” rating and a $44.00 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of CareFusion from $48.00 to $50.00 in a research note on Monday, May 19th. They now have a “strong-buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of CareFusion in a research note on Wednesday, May 7th. They now have a $41.00 price target on the stock. Five research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $42.45.

CareFusion Corporation (NYSE:CFN) is a global medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.